Clinical Trials Browser

Adenocarcinoma Of Esophagus, Uveal Melanoma, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Esophageal Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Melanoma, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Rectal Neoplasms, Somatostatinoma, Stomach Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT00111774 2013-05-14

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

Phase 2 Completed

150 enrolled

Gastrointestinal

Carcinoma, Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00988936 2012-08-22

K5-101

Phase 2 Completed

35 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms

NCT00080834 2012-05-16

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00137878 2012-02-23

TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

NCT00113776 2011-01-21

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00421824 2011-01-04

Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer

Phase 2 Completed

108 enrolled

Gastrointestinal

Rectal Neoplasms

NCT00174616 2009-12-07

CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

Phase 2 Completed

87 enrolled

Gastrointestinal

Rectal Neoplasms

NCT00263029 2009-09-18

PROCTFUL

Phase 2 Completed

18 enrolled

Gastrointestinal

Rectal Neoplasms

NCT00063427 2009-08-21

Study Evaluating MAC-321 in Colorectal Cancer

Phase 2 Completed

45 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00072748 2009-08-21

Study Evaluating EKB-569 in Advanced Colorectal Cancer

Phase 2 Completed

63 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00330915 2009-07-21

A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

Phase 2 Completed

37 enrolled 18 charts

Gastrointestinal

Rectal Neoplasms

NCT00235898 2008-08-25

Clinical Trial in Patients With Metastatic Colorectal Cancer

Phase 2 Completed

300 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00590278 2008-01-25

TOMUDEX

Phase 2 Completed

49 enrolled

Gastrointestinal

Rectal Neoplasms

Clinical Trials

SEAMARK

DEL-LIVER

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

AZUR-1

China AZUR-1

COMPANION-003

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

MK-0646-025

Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX

A Study of Ramucirumab or Icrucumab in Colorectal Cancer

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial

INOVA

SPRINT

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Pre-op Rectal ChemoRad +/- Cetuximab

QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma

A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

STEPP

PRECEPT

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

K5-101

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer

CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

PROCTFUL

Study Evaluating MAC-321 in Colorectal Cancer

Study Evaluating EKB-569 in Advanced Colorectal Cancer

A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

Clinical Trial in Patients With Metastatic Colorectal Cancer

TOMUDEX